Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease |
| |
Authors: | Marianthi Papagianni Areti Sofogianni Konstantinos Tziomalos First Propedeutic |
| |
Affiliation: | Marianthi Papagianni;Areti Sofogianni;Konstantinos Tziomalos;First Propedeutic Department of Internal Medicine,Medical School, Aristotle University of Thessaloniki, AHEPA Hospital; |
| |
Abstract: | Nonalcoholic fatty liver disease(NAFLD) is the commonest chronic liver disease and includes simple steatosis and nonalcoholic steatohepatitis(NASH). Since NASH progresses to cirrhosis more frequently and increases liver-related and cardiovascular disease risk substantially more than simple steatosis, there is a great need to differentiate the two entities. Liver biopsy is the gold standard for the diagnosis of NAFLD but its disadvantages, including the risk of complications and sampling bias, stress the need for developing alternative diagnostic methods. Accordingly, several non-invasive markers have been evaluated for the diagnosis of simple steatosis and NASH, including both serological indices and imaging methods. The present review summarizes the current knowledge on the role of these markers in the diagnosis of NAFLD. Current data suggest that ultrasound and the fibrosis-4 score are probably the most appealing methods for detecting steatosis and for distinguishing NASH from simple steatosis, respectively, because of their low cost and relatively high accuracy. However, currently available methods, both serologic and imaging, cannot obviate the need for liver biopsy for diagnosing NASH due to their substantial false positive and false negative rates. Therefore, the current role of these methods is probably limited in patients who are unwilling or have contraindications for undergoing biopsy. |
| |
Keywords: | Nonalcoholic steatohepatitis Steatosis Fibrosis Imaging Nonalcoholic fatty liver disease |
本文献已被 CNKI 等数据库收录! |
|